https://www.biotechblueprint.com/p/the-first-in-vivo-crispr-therapyBiotech Blueprinten2026-05-01T11:23:18+00:00The First In Vivo CRISPR Therapy to Win a Phase 3 Trial, and the $1.9B Acquisition Made Two Days Later – This Week in Biotech #98